Latest News & Features
Big Pharma
A new EU policy will require pharmaceutical companies to provide clinical trial data when seeking marketing approval for their drugs. But how will they ensure adequate IP protection while embracing the new culture of transparency? LSIPR reports. 25 November 2014
Americas
US pharmaceutical company Supernus Pharmaceuticals has sued Zydus Pharmaceuticals and Cadila Healthcare accusing them of infringing patents covering its antiepileptic drug, Trokendi XR (topiramate). 25 November 2014
Americas
Steptoe & Johnson has added a partner to its New York IP team. 24 November 2014
Europe
A lawyer from GlaxoSmithKline has said the Unified Patent Court will take ten years to overcome teething problems. 20 November 2014
Americas
Indian drug maker Ranbaxy Laboratories has sued the US Food and Drug Administration and claimed it wrongfully revoked a previous approval for two new drugs. 19 November 2014
Americas
US-based law firm Quarles & Brady has expanded its life sciences team with the addition of a new partner. 18 November 2014
Biotechnology
The US Court of Appeals for the Federal Circuit has denied pharmaceutical company Antares Pharma an injunction that aimed to block a rival from allegedly infringing a patent covering injection devices. 18 November 2014
Asia
The heads of the European Patent Office and China’s IP office have pledged to work together to improve innovation and future partnerships. 17 November 2014
Americas
US pharmaceutical company Sucampo Pharmaceuticals has sued India-based Dr. Reddy’s Laboratories, asserting patents covering its constipation treatment Amitiza (lubiprostone). 13 November 2014
Big Pharma
The sale of counterfeit drugs is the target of new legislation proposed by the Russian government, according to news agency Tass. 12 November 2014